BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10465695)

  • 1. Neuroprotective mechanism of glial cell line-derived neurotrophic factor on dopamine neurons: role of antioxidation.
    Chao CC; Lee EH
    Neuropharmacology; 1999 Jun; 38(6):913-6. PubMed ID: 10465695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced glial cell line-derived neurotrophic factor mRNA expression upon (-)-deprenyl and melatonin treatments.
    Tang YP; Ma YL; Chao CC; Chen KY; Lee EH
    J Neurosci Res; 1998 Sep; 53(5):593-604. PubMed ID: 9726430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
    Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
    Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glial cell line-derived neurotrophic factor induced intracellular activity by K-252b on dopaminergic neurons.
    Pong K; Xu RY; Beck KD; Zhang TJ; Louis JC
    J Neurochem; 1997 Sep; 69(3):986-94. PubMed ID: 9282920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium.
    Hou JG; Lin LF; Mytilineou C
    J Neurochem; 1996 Jan; 66(1):74-82. PubMed ID: 8522992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine.
    Cass WA
    J Neurosci; 1996 Dec; 16(24):8132-9. PubMed ID: 8987838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of the neurotrophic effect of GDNF on DA neurons: role of protein kinase CK2.
    Chao CC; Chiang CH; Ma YL; Lee EH
    Neurobiol Aging; 2006 Jan; 27(1):105-18. PubMed ID: 16298246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of GDNF on nigrostriatal dopaminergic function in response to a two-pulse K(+) stimulation.
    Xu K; Dluzen DE
    Exp Neurol; 2000 Dec; 166(2):450-7. PubMed ID: 11085910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
    Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
    Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats.
    Lu X; Hagg T
    J Comp Neurol; 1997 Nov; 388(3):484-94. PubMed ID: 9368855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue.
    Yurek DM
    Exp Neurol; 1998 Oct; 153(2):195-202. PubMed ID: 9784279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET.
    Opacka-Juffry J; Ashworth S; Hume SP; Martin D; Brooks DJ; Blunt SB
    Neuroreport; 1995 Dec; 7(1):348-52. PubMed ID: 8742486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immortalized dopamine neurons: A model to study neurotoxicity and neuroprotection.
    Clarkson ED; Edwards-Prasad J; Freed CR; Prasad KN
    Proc Soc Exp Biol Med; 1999 Nov; 222(2):157-63. PubMed ID: 10564540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmented methamphetamine-induced overflow of striatal dopamine 1 day after GDNF administration.
    Cass WA; Walker DJ; Manning MW
    Brain Res; 1999 May; 827(1-2):104-12. PubMed ID: 10320698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: involvement of the glutathione system.
    Hou JG; Cohen G; Mytilineou C
    J Neurochem; 1997 Jul; 69(1):76-83. PubMed ID: 9202296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members.
    Gratacòs E; Pérez-Navarro E; Tolosa E; Arenas E; Alberch J
    J Neurochem; 2001 Sep; 78(6):1287-96. PubMed ID: 11579137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons.
    Granholm AC; Reyland M; Albeck D; Sanders L; Gerhardt G; Hoernig G; Shen L; Westphal H; Hoffer B
    J Neurosci; 2000 May; 20(9):3182-90. PubMed ID: 10777782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo.
    Kearns CM; Gash DM
    Brain Res; 1995 Feb; 672(1-2):104-11. PubMed ID: 7749731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
    Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
    Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.